# ClinicalTrials.gov record NCT05151484

> PeptideScanner retained ClinicalTrials.gov record NCT05151484 at 2026-07-30T16:19:36.911Z. Its registry update date was 2026-05-14, and PeptideScanner's reviewed identity mapping was teriparatide.

- Evidence object: `story:clinicaltrials-gov-nct05151484-teriparatide:v1`
- Evidence domain: Clinical trials
- Date in source: 2026-05-14
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-09
- Story landing page: https://peptidescanner.com/stories/clinicaltrials-gov-nct05151484-teriparatide/
- JSON record: https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct05151484-teriparatide-v1.json
- Content SHA-256: `afdd6128afcd8e50d2e5054dc881edc1ba73459ca3b9966ab504779da072056b`

## Claims and source pins

### Headline

ClinicalTrials.gov record NCT05151484 ([`ctg-observation-nct05151484-2026-05-14-aef6e24e3c94`](#source-ctg-observation-nct05151484-2026-05-14-aef6e24e3c94))

### Summary

PeptideScanner retained ClinicalTrials.gov record NCT05151484 at 2026-07-30T16:19:36.911Z. Its registry update date was 2026-05-14, and PeptideScanner's reviewed identity mapping was teriparatide. ([`ctg-observation-nct05151484-2026-05-14-aef6e24e3c94`](#source-ctg-observation-nct05151484-2026-05-14-aef6e24e3c94))

### Paragraph 1

PeptideScanner retained ClinicalTrials.gov record NCT05151484 at 2026-07-30T16:19:36.911Z. Its registry update date was 2026-05-14, and PeptideScanner's reviewed identity mapping was teriparatide. ([`ctg-observation-nct05151484-2026-05-14-aef6e24e3c94`](#source-ctg-observation-nct05151484-2026-05-14-aef6e24e3c94))

### Paragraph 2

This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. ([`ctg-observation-nct05151484-2026-05-14-aef6e24e3c94`](#source-ctg-observation-nct05151484-2026-05-14-aef6e24e3c94))

## Sources

<a id="source-ctg-observation-nct05151484-2026-05-14-aef6e24e3c94"></a>
- **ClinicalTrials.gov record NCT05151484 · retained source version 2026-05-14:aef6e24e3c94174aa08e82b7472b42ea3098cb6e21eb6b70029c75dc4e2cb0d3** — ClinicalTrials.gov; class A. [Open source](https://clinicaltrials.gov/study/NCT05151484) (`ctg-observation-nct05151484-2026-05-14-aef6e24e3c94`)

## Correction lineage

No correction is recorded for this version.

## Reporting boundaries and unknowns

PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

## Suggested citation

PeptideScanner. "ClinicalTrials.gov record NCT05151484." Version 1, published 2026-08-09. https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct05151484-teriparatide-v1.json SHA-256: afdd6128afcd8e50d2e5054dc881edc1ba73459ca3b9966ab504779da072056b.